Director, Specialty Pharmacy & Patient Support Program at Axsome Therapeutics Inc

Brisbane, California, United States

Axsome Therapeutics Inc Logo
Not SpecifiedCompensation
Expert & Leadership (9+ years)Experience Level
Full TimeJob Type
UnknownVisa
Biotechnology, PharmaceuticalsIndustries

Requirements

  • Experience in specialty pharmacy networks and patient support programs (PSP-HUB)
  • Ability to oversee and manage daily operations and collaboration with SP network providers and PSP-HUB
  • Leadership in coordinating field teams (Sales, Field Reimbursement Managers, Regional Marketing Directors) with specialty and patient support resources
  • Expertise in documenting, evaluating, investigating, and resolving escalations timely
  • Knowledge of Patient Assistance Program (PAP) and 340B Program to support field teams
  • Dynamic talent fitting a clinical-stage biotechnology company culture focused on immunological diseases

Responsibilities

  • Accountable for the development and management of the field escalation program/process to assure collaboration and communication between field teams, Trade & Distribution, Specialty Pharmacy, Patient Support team, and external partners
  • Collaborate with the development, revision, and execution of specialty pharmacy and Patient Support Program - HUB programs/services designed to facilitate the initiation and maintenance of patient therapy treatment
  • Support the supervision of the day-to-day SP and PSP-HUB operations to ensure appropriate support across key customer interactions including HCPs/Office Staff, Patients/Caregivers, and Vera Field teams
  • Provide “valuable” field insights in the creation/revision of marketing materials (Patient Referral Form, Welcome Kit, HCP Office Resource Guide, etc.) to support patient therapy access, HCP adoption of Vera products, and field force training
  • Collaborate in the development of tools and processes to educate and inform key Vera internal and external stakeholders including data, dashboards, and stakeholder presentations
  • Work with sales personnel, HCPs, SP, and HUB partners to monitor ongoing performance of the programs and identify revision requirements based upon “real time” data and issues

Skills

Specialty Pharmacy
Patient Support Program
HUB Services
Trade Distribution
Product Distribution
Patient Journey
Pharmaceutical Operations
Access and Value

Axsome Therapeutics Inc

Develops therapies for CNS disorders

About Axsome Therapeutics Inc

Axsome Therapeutics develops therapies for central nervous system (CNS) disorders, focusing on conditions like major depressive disorder, treatment-resistant depression, and Alzheimer's agitation. Their main product, AXS-05, is an oral medication that works by blocking NMDA receptors in the brain, which helps regulate mood. This drug has shown positive results in clinical trials and has received special FDA status to speed up its approval process. Unlike many competitors, Axsome emphasizes addressing unmet medical needs in CNS disorders and aims to improve patient outcomes through rigorous research and development. The company's goal is to bring effective treatments to market, enhancing the quality of life for patients suffering from these conditions.

New York City, New YorkHeadquarters
2012Year Founded
$430.7MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
201-500Employees

Benefits

Performance Bonus
Company Equity

Risks

Increased competition from companies like Compass Pathways in the CNS market.
Potential delays in AXS-07 launch amid growing market anticipation.
Departure of key personnel like Lori Englebert may impact strategic direction.

Differentiation

Axsome focuses on CNS disorders with limited current treatment options.
AXS-05, an NMDA receptor antagonist, targets major depressive disorder and treatment-resistant depression.
Axsome's balanced portfolio includes both clinical and research stage products.

Upsides

FDA's fast-tracking of CNS treatments could expedite Axsome's drug approvals.
Increased investment in CNS R&D drives innovation, benefiting Axsome's pipeline.
Growing personalized medicine trend offers Axsome opportunities for tailored therapies.

Land your dream remote job 3x faster with AI